About Apoptosis inhibitor 5
Apoptosis inhibitor 5 (API5) is a protein
from Homo sapiens identified by UniProt accession
Q9BZZ5, 524 residues long.
MolForge cross-references it against 0 known binders and
70 disease associations.
Target properties
| Protein name | Apoptosis inhibitor 5 |
| UniProt accession | Q9BZZ5 |
| Gene | API5 |
| Organism | Homo sapiens |
| Length | 524 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (70)
Diseases linked to this target (Open Targets).
- refractive error · score 0.27
- PHF-tau measurement · score 0.19
- drug use measurement · score 0.19
- Abnormality of refraction · score 0.18
- self reported educational attainment · score 0.17
- monocyte percentage of leukocytes · score 0.16
- mathematical ability · score 0.16
- neutrophil count · score 0.14
- neutrophil percentage of leukocytes · score 0.14
- adolescent idiopathic scoliosis · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BZZ5-F1 | alphafold | PREDICTED | 84.63 | — |
Amino-acid sequence (524 residues)
MPTVEELYRN YGILADATEQ VGQHKDAYQV ILDGVKGGTK EKRLAAQFIP KFFKHFPELA DSAINAQLDL CEDEDVSIRR QAIKELPQFA TGENLPRVAD ILTQLLQTDD SAEFNLVNNA LLSIFKMDAK GTLGGLFSQI LQGEDIVRER AIKFLSTKLK TLPDEVLTKE VEELILTESK KVLEDVTGEE FVLFMKILSG LKSLQTVSGR QQLVELVAEQ ADLEQTFNPS DPDCVDRLLQ CTRQAVPLFS KNVHSTRFVT YFCEQVLPNL GTLTTPVEGL DIQLEVLKLL AEMSSFCGDM EKLETNLRKL FDKLLEYMPL PPEEAENGEN AGNEEPKLQF SYVECLLYSF HQLGRKLPDF LTAKLNAEKL KDFKIRLQYF ARGLQVYIRQ LRLALQGKTG EALKTEENKI KVVALKITNN INVLIKDLFH IPPSYKSTVT LSWKPVQKVE IGQKRASEDT TSGSPPKKSS AGPKRDARQI YNPPSGKYSS NLGNFNYEQR GAFRGSRGGR GWGTRGNRSR GRLY
Explore Apoptosis inhibitor 5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets